Current and potential use of GLP-1R agonists: beyond type 2 diabetes
Intestinal incretins, glucagon-like peptide 1 (GLP-1), and gastric insulinotropic peptide, which are released after food ingestion, have glucoregulatory effects, which is why, in recent years, pharmacological agents with an impact similar to incretins have been developed. The results of GLP-1 and it...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Permanyer
2024-10-01
|
| Col·lecció: | Revista Mexicana de Endocrinología, Metabolismo y Nutrición |
| Matèries: | |
| Accés en línia: | http://www.revistadeendocrinologia.com/frame_eng.php?id=350 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|